Amniotic cells protect and repair mouse brain cells following ischemia-reperfusion injury

Chinese Journal of Tissue Engineering Research

Volumn 18, Issue 37, 2014, Pages 6024-6028

  Zheng, Yan Tao ^a   Liu, Bin ^a   Lodato, Robert ^b   Li, Qi Lin ^a   Lan, Di Hui ^a   Hong, Xiao Ying ^c   Xian, Hua ^c  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS   (United States)

^c THE THIRD AFFILIATED HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Amnion; Cell cycle; Flow cytometry; Reperfusion injury

Indexed keywords

AMNION CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTERY OCCLUSION; ARTICLE; BRAIN CELL; BRAIN ISCHEMIA; CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL FUNCTION; CELL PROTECTION; CELL REGENERATION; CELL VIABILITY; COMMON CAROTID ARTERY; CONTROLLED STUDY; MOUSE; NONHUMAN; PLACENTA; REPERFUSION INJURY;

EID: 84930076501     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.2095-4344.2014.37.022     Document Type: Article

References (25)

1. Chen J, Zhang C, Jiang H, et al. Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J Cereb Blood Flow Metab. 2005;25(2):281-290.
2. Kakishita K, Nakao N, Sakuragawa N, et al. Implantation of human amniotic epithelial cells prevents the degeneration of nigral dopamine neurons in rats with 6-hydroxydopamine lesions. Brain Res. 2003;980(1):48-56.
3. Barker RA, Dunnett SB, Faissner A, et al. The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp Neurol. 1996;141(1):79-93.
4. Nakao N, Shintani-Mizushima A, Kakishita K, et al. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease. Brain Res Rev. 2006;52(2):244-256.
5. Brundin P, Karlsson J, Emgård M, et al. Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant. 2000;9(2):179-195.
6. Ziv I, Offen D, Barzilai A, et al. Modulation of control mechanisms of dopamine-induced apoptosis--a future approach to the treatment of Parkinson's disease? J Neural Transm Suppl. 1997;49:195-202.
7. Ziv I, Barzilai A, Offen D, et al. Nigrostriatal neuronal death in Parkinson's disease--a passive or an active genetically-controlled process? J Neural Transm Suppl. 1997; 49:69-76.
8. Ueda S, Sakakibara S, Watanabe E, et al. Vulnerability of monoaminergic neurons in the brainstem of the zitter rat in oxidative stress. Prog Brain Res. 2002;136:293-302.
9. González-Hernández T, Afonso-Oramas D, Cruz-Muros I. Phenotype, compartmental organization and differential vulnerability of nigral dopaminergic neurons. J Neural Transm Suppl. 2009 (73):21-37.
10. Prasad KN, Clarkson ED, La Rosa FG, et al. Efficacy of grafted immortalized dopamine neurons in an animal model of parkinsonism: a review. Mol Genet Metab. 1998;65(1):1-9.
11. Mena MA, de Bernardo S, Casarejos MJ, et al. The role of astroglia on the survival of dopamine neurons. Mol Neurobiol. 2002;25(3):245-263.
12. Ebendal T, Lönnerberg P, Pei G, et al. Engineering cells to secrete growth factors. J Neurol. 1994;242(1 Suppl 1):S5-7.
13. Sun E. Cell death recognition model for the immune system. Med Hypotheses. 2008;70(3):585-596.
14. Liu J, Li J, Yang Y, et al. Neuronal apoptosis in cerebral ischemia/reperfusion area following electrical stimulation of fastigial nucleus. Neural Regen Res. 2014;9(7):727-734.
15. Minina EA, Bozhkov PV, Hofius D. Autophagy as initiator or executioner of cell death. Trends Plant Sci. 2014. in press.
16. Wei B, Yue P, Qingwei L. The molecular mechanism of necroptosis. Yi Chuan. 2014;36(6):519-524.
17. Wang K. Molecular mechanisms of liver injury: Apoptosis or necrosis. Exp Toxicol Pathol. 2014;66(8):351-356.
18. Beesoo R, Neergheen-Bhujun V, Bhagooli R, et al. Apoptosis inducing lead compounds isolated from marine organisms of potential relevance in cancer treatment. Mutat Res Fundam Mol Mech Mutagen. 2014. in press.
19. Cerella C, Teiten MH, Radogna F, et al. From nature to bedside: Pro-survival and cell death mechanisms as therapeutic targets in cancer treatment. Biotechnol Adv. 2014; 32(6):1111-1122.
20. Tian XF, Cui MX, Yang SW, et al. Cell death, dysglycemia and myocardial infarction. Biomed Rep. 2013;1(3):341-346.
21. Kim SH, Choi KC. Anti-cancer Effect and Underlying Mechanism(s) of Kaempferol, a Phytoestrogen, on the Regulation of Apoptosis in Diverse Cancer Cell Models. Toxicol Res. 2013;29(4):229-234.
22. Li ZM, Chu FL, Liu Y, et al. Progress on mechanism of cell apoptosis induced by rubella virus. Bing Du Xue Bao. 2013; 29(5):578-582.
23. Reyjal J, Cormier K, Turcotte S. Autophagy and cell death to target cancer cells: exploiting synthetic lethality as cancer therapies. Adv Exp Med Biol. 2014;772:167-188.
24. Bincoletto C, Bechara A, Pereira GJ, et al. Interplay between apoptosis and autophagy, a challenging puzzle: new perspectives on antitumor chemotherapies. Chem Biol Interact. 2013;206(2):279-288.
25. Zimmerman MA, Huang Q, Li F, et al. Cell death-stimulated cell proliferation: a tissue regeneration mechanism usurped by tumors during radiotherapy. Semin Radiat Oncol. 2013; 23(4):288-295.